Cargando…
Adjuvant imatinib for patients with high-risk gastrointestinal stromal tumors: a retrospective cohort study
The duration of adjuvant imatinib for high-risk patients with gastrointestinal stromal tumors (GISTs) is still controversial. Therefore, we retrospectively analyzed the data of high-risk patients with GISTs to investigate the appropriate duration. All 185 patients were divided into 4 groups: <1 y...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715066/ https://www.ncbi.nlm.nih.gov/pubmed/29203825 http://dx.doi.org/10.1038/s41598-017-17266-5 |